Prostate Cancer Screening Test (PSA)…A Waste of Time!

  • No level of Prostate Specific Antigen (PSA) completely excludes prostate cancer.
  • The prevalence of undiagnosed prostate cancer at autopsy is high and increases with age (> 40% among men aged 40-49 yr to > 70% among men aged 70-79 yr)
  • Only a small proportion of men with prostate cancer have symptoms or die from the disease; most prostate cancers are slowly progressive and NOT LIFE THREATENING.
  • Screening with the PSA test may lead to a small reduction in prostate cancer death but NOT a reduction in all-cause death rate.

The PSA test should NOT be used for screening without a detailed discussion with the patient, ideally with the use of decision aids to facilitate comprehension.

Emergency Medicine Kenya Foundation

Join Our Newsletter

Please complete this form to create an account, receive email updates and much more.
Contact Email *
First Name *
Last Name *
Facility or Organisation *
Designation or Occupation *
County or City *
Country *
Mobile number 
*Required Fields
I agree to the Privacy Policy and Terms of Use. It is our responsibility to protect your privacy and we guarantee that your data will be completely confidential.
Strengthening emergency healthcare systems in Kenya to save lives.